Stockreport

4D Molecular Therapeutics downgraded at Cantor following wet AMD asset data [Seeking Alpha]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF Although the company claimed that the data showed robust and durable results, shares plunged ~20% the following day followed by a 12% drop on Sept. 20. The fi [Read more]